Effect of Bortezomib on Human Neuroblastoma Cell Growth, Apoptosis, and Angiogenesis-Reference-Cited by-同舟云学术

Effect of Bortezomib on Human Neuroblastoma Cell Growth, Apoptosis, and Angiogenesis

Published:2006-08-16 Issue:16 Volume:98 Page:1142-1157
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Brignole Chiara,Marimpietri Danilo,Pastorino Fabio,Nico Beatrice,Di Paolo Daniela,Cioni Michela,Piccardi Federica,Cilli Michele,Pezzolo Annalisa,Corrias Maria Valeria,Pistoia Vito,Ribatti Domenico,Pagnan Gabriella,Ponzoni Mirco

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/98/16/1142/7687575/djj309.pdf

Reference73 articles.

1. Maris JM, Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol1999 ; 17 : 2264 –79.

2. De Bernardi B, Nicolas B, Boni L, Indolfi P, Carli M, Cordero Di Montezemolo L, et al. Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-operative Group for Neuroblastoma. J Clin Oncol2003 ; 21 : 1592 –601.

3. Rajkumar SV, Richardson PG, Hideshima T, Anderson KC. Proteasome inhibition as a novel therapeutic target in human cancer. J Clin Oncol2005 ; 23 : 630 –9.

4. Mani A, Gelmann EP. The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol2005 ; 23 : 4776 –89.

5. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev2002 ; 82 : 373 –428.

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutting edge of immune response and immunosuppressants in allogeneic and xenogeneic islet transplantation;Frontiers in Immunology;2024-09-13

2. Nuclear factor-κB activation by transforming growth factor-β1 drives tumour microenvironment-mediated drug resistance in neuroblastoma;British Journal of Cancer;2024-05-28

3. Spatial sequestration of activated-caspase 3 in aggresomes mediates resistance of neuroblastoma cell to bortezomib treatment;Scientific Reports;2024-02-14

4. ADGRL4 Promotes Cell Growth, Aggressiveness, EMT, and Angiogenesis in Neuroblastoma via Activation of ERK/STAT3 Pathway;Current Molecular Medicine;2024-01-03

5. Bortezomib Is Toxic but Induces Neurogenesis and Inhibits TUBB3 Degradation in Rat Neural Stem Cells;Biomolecules & Therapeutics;2023-12-11